MRSN - Mersana Therapeutics Company Long-Term Liabilities

Mersana Therapeutics (MRSN) develops therapies for the female reproductive system in US centers using targeted toxin delivery. The price history reflects debt at the level of 0.00. The firm relies on the work of oncology laboratories and the readiness of plants for mass production. Leadership in the ADC segment and the Dolaflexin platform enable the company to effectively capture the ovarian cancer treatment market.

Mersana Therapeutics (MRSN) Company Long-Term Debt: for the period 07/04/2022 - 01/17/2026

Mersana Therapeutics, Inc. - analytical breakdowns and key metrics (MRSN)

- share price and expert price forecast:

Share Price Mersana Therapeutics Inc|MRSN - Analyst Consensus Forecast

- market capitalization statistics:

Market Valuation Mersana Therapeutics|MRSN - Enterprise Value

- shareholders' equity book value data:

Net Asset Value per Share Mersana Therapeutics|MRSN - Company Book Value|Market Value to Book Value mersana.com|MRSN - Cumulative Company Assets

- business debt structure and liquidity details:

- earnings and market multiples details:

MRSN - Company Net Income

Analysis of all company metrics:Mersana Therapeutics

For Mersana Therapeutics (MRSN), which invests in the development of the Dolaflexin ADC platform and clinical trials of upifitamab rutenecan, external financing is critical to cover R&D expenses. By analyzing changes in the issuer's long-term liabilities, an investor assesses the total loans with maturities exceeding one year, which allows for the determination of the company's financial leverage and its resilience to rising interest rates while scaling drug development.

Competitors of Mersana Therapeutics (MRSN)

MRUS: Company Long-Term Indebtedness|Immutep - Company Long-Term Debts|Anixa Biosciences (ANIX) - Company Long-Term Liabilities|ATOS: Company Long-Term Debts|Long-Term Debt Context Therapeutics Inc. (CNTX)|Company Long-Term Debt BriaCell Therapeutics|EPIX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities QTI (QT Imaging)